Navigation Links
Barrier Therapeutics to Merge Into Stiefel Laboratories
Date:6/23/2008

l network is comprised of more than 30 subsidiaries, manufacturing plants in six countries, research and development facilities on four continents, and products marketed in more than 100 countries around the world.

Stiefel Laboratories supplements its R&D efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel Laboratories, Inc. visit http://www.stiefel.com.

Important Information About the Tender Offer

This announcement and the description contained herein are informational purposes only and are not an offer to purchase or a solicitation of an offer to sell securities of Barrier Therapeutics. The tender offer described herein has not yet been commenced. At the time the tender offer is commenced, Stiefel Laboratories and its wholly-owned subsidiary intend to file a tender offer statement on a Schedule TO containing an offer to purchase, a letter of transmittal and other related documents with the Securities and Exchange Commission. At the time the tender offer is commenced, Barrier Therapeutics intends to file with the Securities and Exchange Commission a solicitation/recommendation statement on Schedule 14D-9 and, if required, will file a proxy statement or information statement with the Securities and Exchange Commission in connection with the merger, the second step of the transaction, at a later date. Such documents will be mailed to stockholders of record and will also be made available for distribution to beneficial owners of common stock of Barrier Therapeutics. The solicitation of offers to buy common stock of Barrier Therapeutics will only be made pursuant to the offer to purchase, the letter of transmittal and related documents. Stockholders are advised to read the offer to purchase, the letter of transmittal, the solicitation/recommendation statement, the proxy statement, the information statement and all related documents, if and when s
'/>"/>

SOURCE Stiefel Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nanoengineered barrier invented to protect plastic electronics from water degradation
2. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
3. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
4. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
5. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
6. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
7. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
8. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.
10. Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program
11. Loic Maurel Joins Exonhit Therapeutics to Become CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmace...ce(PTO)hasallowedthepatentapplicationfor,itsnano-p...nologyisahighlyefficientapproachtoincorporatepepti...leoraldeliveryofdrugs,otherwiseadministeredasinjec...appliedtomanymacromoleculardrugssuchasinsulin,inte...
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBio...ration(SFDA)hasapprovedthe,investigationalnewdruga...ninnovativeinsulinformulationtotreatdiabetes.ThisI...inicalstudy. , Diabetesisadisordercharacteris...ationsofdiabetesoftenresultinseveremicro-and,macro...
(Date:11/24/2009)... The FBI recently approved t...atories participating in or generating DNA records... Madison, WI USA (PRWEB) -- The FBI re...System for use by laboratories participating in, ...dex System (NDIS). NDIS currently contains more th...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswi...lyCalottoCapitalInc.,aleadingproviderofadvancedlas...rtilityclinicmarkets,todayreportedoperationalandfi...009. , ,Q32009Highlights,-Revenuewas$1.46million...nwas66.3percentcomparedwith66.1percentinQ3,2008,-N...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...ion to Netsmart,s Avatar Software Platform Further...thcare Solutions for ...chnologies, Inc.,a leading provider of enterprise-...rvices organizations, today announced it has signe...tware and related services to Manatee,Glens of Bra...
... Feb. 6 The Global Probiotics Council,(GPC), a co...akult Honsha,Co., Ltd., announced the Young Invest...RO) today. The two annual grants are designed to s...investigators and attract new,researchers in the U...microbiota., "Our two companies have demonstrated...
...ns Exclusive Rights to Oncology Biomarkers, FREMO...L ), a high-value molecular diagnostics company, t...aboration with Johns Hopkins University,on the dev...oward disease,detection, classification and monito...st and prostate. Vermillion will have access to ex...
Other Biology Technology:Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 2Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 4Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests 2
(Date:11/26/2009)...ntries has shown that closing schools in the event...gnificant role in reducing illness transmission. R... Infectious Diseases compared opportunities for i...ding that they were reduced when schools are shut....y, Belgium, led a team of European researchers in ...
(Date:11/25/2009)...ia Institute of Technology (Caltech) have uncovere... the fruit fly, Drosophila melanogaster . , The...ship between the neurotransmitter dopamine and att...described in the December issue of the journal Ne...out 20,000 neurons and has long been considered a ...
(Date:11/25/2009)...h Research Laboratory in the University of Haifa,s...igious Johnson & Johnson Focused Funding grant for...mage in Parkinson,s disease. The award, which is g...ation and excellence in science, was announced in ...at an event at the Hyatt Regency Hotel in New Jers...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 1NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 2NBCH Issues Guide to Help Employers Design Benefit Plans that Keep People Healthy 58141 3PharmAthene to Present at The Maxim Group Growth Conference September 29 2009 58139 1Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources 58137 1Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources 58137 2
..., GAINESVILLE, Fla. --- How do the French get awa... loaded with saturated fats? Scientists have long ... paradox" lies in red wine. Now, the results of a ... , Writing this week in the online, open-access j...rchers from industry and academia, including the U...
..., Short bursts of high intensity sprintsknown to ... improve the function and structure of blood vesse...ur muscles and heart, according to new research fr...siology doctoral student Mark Rakobowchuk, is publ...ysiology. Regulatory, Integrative & Comparative Ph...
..., , DURHAM, N.H. -- University of New Hampshire r...udy UNH,s organic dairy research farm as a sustain...gies for becoming energy independent. The $380,000...iculture,s Sustainable Agricultural Research and E...losing energy and nutrient cycles could help small...
Other Biology News:Substance in red wine found to keep hearts young 2Substance in red wine found to keep hearts young 3Brief, intense exercise benefits the heart 2UNH receives $380,000 grant to study organic dairy as closed ecosystem 2UNH receives $380,000 grant to study organic dairy as closed ecosystem 3
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Nucleobindin 1 (NUCB1) Antibody, Unconjugated from CHEMICON
RayBio Human Chemokine Antibody Array I & 1.1 Service from Raybiotech, Inc.
...tem cells (HSC) are well-characterized tissue-spec...al capacity and are responsible for the life-long ...are cells that reside in adult bone marrow where h...n also be found in cord blood, fetal liver, adult ...
Biology Products: